Exclusive Preview of eSTEP on demand content from ESOC 2024: The session by Mark Parsons "Tenecteplase vs Alteplase for Stroke Thrombolysis Evaluation with Perfusion Imaging Selection within 4-5 hours of Onset (TASTE): a multicentre, randomised, controlled phase III non-inferiority trial"
Негізгі бет ESOC 2024 Session on demand: The TASTE trial
Пікірлер